Computed Tomography (CT) in Head and Neck Patients

This study is currently recruiting participants.

Verified by University Health Network, Toronto, September 2005

Sponsored by:	University Health Network, Toronto
Information provided by:	University Health Network, Toronto
ClinicalTrials.gov Identifier:	NCT00188656

Purpose

This study is conducting a comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT) in the detection of lung nodules (metastases) in patients with head and neck carcinoma.

Condition	Intervention	Phase
Lung Tumors	Procedure: CT thorax	Phase I

MedlinePlus related topics: Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:	Minimum Dose CT in the Detection of Lung Nodules in Patients With Head and Neck Cancer

Further study details as provided by University Health Network, Toronto:

Primary Outcome Measures:

Detection of lung metastases

Estimated Enrollment:	100
Study Start Date:	August 2003

Detailed Description:

A comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT)in the detection of lung nodules (metastases) in patients with head and neck carcinoma

Eligibility

Ages Eligible for Study:	16 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients with squamous cell carcinoma of the head and neck

Exclusion Criteria:

None

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00188656

Contacts

Contact: Narinder Paul, FRCP C

416-946-2000 ext 4846

narinder.paul@uhn.on.ca

Locations

Canada, Ontario
Princess Margaret Hospital	Recruiting
Toronto, Ontario, Canada
Contact: Narinder Paul, FRCP C 416-946-2000 ext 4846 narinder.paul@uhn.on.ca
Principal Investigator: Narinder Paul, FRCP C
Principal Investigator: Narinder Paul, FRCP C

Sponsors and Collaborators

University Health Network, Toronto

Investigators

Principal Investigator:

Narinder Paul, FRCP C

University Health Network, Toronto

More Information

Study ID Numbers:	03-0467
Study First Received:	September 12, 2005
Last Updated:	February 21, 2006
ClinicalTrials.gov Identifier:	NCT00188656
Health Authority:	Canada: Health Canada

Study placed in the following topic categories:

Lung Neoplasms
Head and Neck Neoplasms

ClinicalTrials.gov processed this record on January 16, 2009